# Copper Cu 64 Dotatate for the Detection, Localization and Monitoring of SSTR Expressing (NETs)

> **NCT04334837** · — · APPROVED_FOR_MARKETING · sponsor: **Curium US LLC**

## Conditions studied

- Neuroendocrine Tumors

## Interventions

- **DIAGNOSTIC_TEST:** Copper Cu 64 Dotatate

## Key facts

- **NCT ID:** NCT04334837
- **Lead sponsor:** Curium US LLC
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** APPROVED_FOR_MARKETING
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2020-10-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04334837

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04334837, "Copper Cu 64 Dotatate for the Detection, Localization and Monitoring of SSTR Expressing (NETs)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04334837. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*